BDRX (Biodexa Pharmaceuticals) DeferredTaxAndRevenue: $0.76 Mil (As of Dec. 2025)


BDRX Biodexa Pharmaceuticals PLC BDRX
24 GF Score
Price $2.49
View Full Analysis

What is Biodexa Pharmaceuticals DeferredTaxAndRevenue?

Biodexa Pharmaceuticals BDRX -3.86% 24 DeferredTaxAndRevenue is $0.76 Mil as of Dec. 2025. GuruFocus rates BDRX with a GF Score™ of 24/100.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Biodexa Pharmaceuticals's current deferred tax and revenue for the quarter that ended in Dec. 2025 was $0.76 Mil.

Biodexa Pharmaceuticals DeferredTaxAndRevenue Related Terms

Biodexa Pharmaceuticals DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for Biodexa Pharmaceuticals's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biodexa Pharmaceuticals DeferredTaxAndRevenue Chart

Biodexa Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
DeferredTaxAndRevenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.24 0.00 1.86 0.76

Biodexa Pharmaceuticals Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 1.86 0.00 0.76
BDRX
24GF Score
Biodexa Pharmaceuticals PLC BDRX
DeferredTaxAndRevenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of $0.76 Mil mean?
Biodexa Pharmaceuticals (BDRX) has a DeferredTaxAndRevenue of $0.76 Mil as of Dec. 2025. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Biodexa Pharmaceuticals.
Is Biodexa Pharmaceuticals' DeferredTaxAndRevenue too high?
Biodexa Pharmaceuticals' current DeferredTaxAndRevenue is $0.76 Mil. Overall, Biodexa Pharmaceuticals has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Biodexa Pharmaceuticals' DeferredTaxAndRevenue compare to ADTX and AAGH?
Biodexa Pharmaceuticals' DeferredTaxAndRevenue of $0.76 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Biotechnology company?
A good DeferredTaxAndRevenue depends on the Biotechnology industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Biodexa Pharmaceuticals. Biodexa Pharmaceuticals's current DeferredTaxAndRevenue is $0.76 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biodexa Pharmaceuticals stock overvalued right now?
Biodexa Pharmaceuticals (BDRX) has a current DeferredTaxAndRevenue of $0.76 Mil. The current DeferredTaxAndRevenue is $0.76 Mil. Biodexa Pharmaceuticals' overall GF Score™ is 24/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For Biodexa Pharmaceuticals (BDRX), the current DeferredTaxAndRevenue is $0.76 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biodexa Pharmaceuticals Business Description

Address 1 Caspian Point, Caspian Way, Cardiff, GBR, CF10 4DQ
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
24GF Score

Get the complete analysis for BDRX

DeferredTaxAndRevenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.49
Price